Catalyst Wire Dossier Catalyst Wire Dossier

Fluvastatin Sodium Extended-Release Tablets

fluvastatin sodium · Shenzhen Salubris Pharmaceuticals Co., Ltd.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Fluvastatin Sodium Extended-Release Tablets, covering 2025-02-17 to 2025-02-17. Get the full timeline:

Most recent: Clinical Trial Update: Bioequivalence Study of Fluvastatin Sodium Extended Release Tablets in Healthy Participants [Phase 1]

See pricing